These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32023587)

  • 1. Relation between HOMA-IR and insulin sensitivity index determined by hyperinsulinemic-euglycemic clamp analysis during treatment with a sodium-glucose cotransporter 2 inhibitor.
    So A; Sakaguchi K; Okada Y; Morita Y; Yamada T; Miura H; Otowa-Suematsu N; Nakamura T; Komada H; Hirota Y; Tamori Y; Ogawa W
    Endocr J; 2020 May; 67(5):501-507. PubMed ID: 32023587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes.
    Okura T; Fujioka Y; Nakamura R; Kitao S; Ito Y; Anno M; Matsumoto K; Shoji K; Matsuzawa K; Izawa S; Okura H; Ueta E; Kato M; Imamura T; Taniguchi SI; Yamamoto K
    Sci Rep; 2022 Feb; 12(1):1896. PubMed ID: 35115614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of cardiac function to insulin resistance as evaluated by hyperinsulinemic-euglycemic clamp analysis in individuals with type 2 diabetes.
    Otowa-Suematsu N; Sakaguchi K; Kaneko A; Ito J; Morita Y; Miura H; Yamada T; So A; Komada H; Okada Y; Hirota Y; Tamori Y; Ogawa W
    J Diabetes Investig; 2021 Dec; 12(12):2197-2202. PubMed ID: 34081831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
    Emoto M; Nishizawa Y; Maekawa K; Hiura Y; Kanda H; Kawagishi T; Shoji T; Okuno Y; Morii H
    Diabetes Care; 1999 May; 22(5):818-22. PubMed ID: 10332688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus.
    Katsuki A; Sumida Y; Urakawa H; Gabazza EC; Murashima S; Morioka K; Kitagawa N; Tanaka T; Araki-Sasaki R; Hori Y; Nakatani K; Yano Y; Adachi Y
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5332-5. PubMed ID: 12414910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea.
    Kang ES; Yun YS; Park SW; Kim HJ; Ahn CW; Song YD; Cha BS; Lim SK; Kim KR; Lee HC
    Metabolism; 2005 Feb; 54(2):206-11. PubMed ID: 15690315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy.
    Okita K; Iwahashi H; Kozawa J; Okauchi Y; Funahashi T; Imagawa A; Shimomura I
    Endocr J; 2013; 60(3):283-90. PubMed ID: 23149658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting and OGTT-derived measures of insulin resistance as compared with the euglycemic-hyperinsulinemic clamp in nondiabetic Finnish offspring of type 2 diabetic individuals.
    Lorenzo C; Haffner SM; Stančáková A; Kuusisto J; Laakso M
    J Clin Endocrinol Metab; 2015 Feb; 100(2):544-50. PubMed ID: 25387258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.
    Ohkura T; Shiochi H; Fujioka Y; Sumi K; Yamamoto N; Matsuzawa K; Izawa S; Kinoshita H; Ohkura H; Kato M; Taniguchi S; Yamamoto K
    Cardiovasc Diabetol; 2013 Jan; 12():21. PubMed ID: 23339473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating complement-1q tumor necrosis factor-α-related protein isoform 5 levels are low in type 2 diabetes patients and reduced by dapagliflozin.
    Zhang C; Luo Y; Liu R; Li X; Yang M; Zhang Y; Li L; Mou H; Guo L; Li J; Liu H; Yang G; Zhang X
    J Diabetes Investig; 2020 Jan; 11(1):88-95. PubMed ID: 31070007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors.
    Alatrach M; Laichuthai N; Martinez R; Agyin C; Ali AM; Al-Jobori H; Lavynenko O; Adams J; Triplitt C; DeFronzo R; Cersosimo E; Abdul-Ghani M
    Diabetes; 2020 Apr; 69(4):681-688. PubMed ID: 31915153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.
    Katsuki A; Sumida Y; Gabazza EC; Murashima S; Furuta M; Araki-Sasaki R; Hori Y; Yano Y; Adachi Y
    Diabetes Care; 2001 Feb; 24(2):362-5. PubMed ID: 11213893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients.
    Latva-Rasku A; Honka MJ; Kullberg J; Mononen N; Lehtimäki T; Saltevo J; Kirjavainen AK; Saunavaara V; Iozzo P; Johansson L; Oscarsson J; Hannukainen JC; Nuutila P
    Diabetes Care; 2019 May; 42(5):931-937. PubMed ID: 30885955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.
    Yokoyama H; Emoto M; Fujiwara S; Motoyama K; Morioka T; Komatsu M; Tahara H; Shoji T; Okuno Y; Nishizawa Y
    Diabetes Care; 2003 Aug; 26(8):2426-32. PubMed ID: 12882874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment.
    Ikeda Y; Suehiro T; Nakamura T; Kumon Y; Hashimoto K
    Endocr J; 2001 Feb; 48(1):81-6. PubMed ID: 11403106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL.
    Clegg LE; Heerspink HJL; Penland RC; Tang W; Boulton DW; Bachina S; Fox RD; Fenici P; Thuresson M; Mentz RJ; Hernandez AF; Holman RR
    Diabetes Care; 2019 Feb; 42(2):318-326. PubMed ID: 30523029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis.
    Elkazzaz SK; Khodeer DM; El Fayoumi HM; Moustafa YM
    Life Sci; 2021 Sep; 280():119018. PubMed ID: 33549594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.
    Matsuhisa M; Yamasaki Y; Emoto M; Shimabukuro M; Ueda S; Funahashi T; Matsuzawa Y
    Diabetes Res Clin Pract; 2007 Jul; 77(1):151-4. PubMed ID: 17081646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of surrogate indexes of insulin sensitivity in acute phase of myocardial infarction based on euglycemic-hyperinsulinemic clamp.
    Moura FA; Carvalho LS; Cintra RM; Martins NV; Figueiredo VN; Quinaglia e Silva JC; Almeida OL; Coelho OR; Sposito AC
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E399-403. PubMed ID: 24347056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity.
    Tripathy D; Almgren P; Tuomi T; Groop L
    Diabetes Care; 2004 Sep; 27(9):2204-10. PubMed ID: 15333485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.